Medications that interact with the MR are used clinically, including fludrocortisone (a strong agonist used in mineralocorticoid replacement therapy) and spironolactone or eplerenone (antagonists of MR used in hypertension treatment, especially in PA). This evidence concerns the gene NR3C2 and hypertensive disorder.